Erectile Dysfunction in Primary Care: Protocol

Authors

  • Francisco Matias Centro de Saúde do Bom Jesus, ACeS Região Autónoma da Madeira – Funchal, Madeira, Portugal
  • Ana Patrício Centro de Saúde do Bom Jesus, ACeS Região Autónoma da Madeira – Funchal, Madeira, Portugal
  • Ferdinando Pereira Serviço de Urologia, Hospital Dr. Nélio Mendonça – Funchal, Madeira, Portugal

DOI:

https://doi.org/10.24915/aup.215

Keywords:

Erectile Dysfunction, Primary Health Care

Abstract

Penile erection is a complex physiological process, dependent on various factors, such as neurological, vascular, muscular and psychological, and fundamental to a man’s sex life and consequent well-being. Erectile dysfunction is defined as the persistent inability to achieve and/or maintain an erection sufficient to allow satisfactory sexual performance. This symptom can significantly affect a man’s quality of life, as well as that of his sexual partners, and is strongly related to modifiable risk factors and cardiovascular disease. Primary health care is the most likely setting to address this issue, and family doctors must be prepared to act appropriately. With this in mind, using the guidelines of the European Association of Urology as the main bibliographic basis and adapting them to clinical practice, this protocol was drawn up to be used in all aspects associated with sexual dysfunction and the patient’s biopsychosocial context. In a practical and organized way, it is intended that, in SOAP record format, it will be possible to assess the patient and offer a therapeutic plan that suits their needs and expectations in order to improve their quality of life and prevent worsening of their individual state of health, without fear of medication or guidance, with the appropriate scientific knowledge.

Downloads

Download data is not yet available.

References

EAU Guidelines. Edn. presented at the EAU Annual Congress Milan 2023. ISBN 978-94-92671-19-6. In https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Sexual-and- Reproductive-Health-2023.pdf

Frias Lopes B, Malheiro Lopes M, Peres J, Queiroz Gonçalves MI, Caseiro T, Pereira M. A DISFUNÇÃO ERÉTIL COMO INDICADOR DE PATOLOGIA CARDIOVASCULAR. RH [Internet]. 26 de Junho de 2022;(89):18-20.

Nehra A, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012 Aug;87(8):766-78. doi: 10.1016/j.mayocp.2012.06.015. PMID: 22862865; PMCID: PMC3498391.

Rosen R, Riley A, Wagner G, et al. The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology, 1997, 49: 822-830.

Erepry, Resumo das Características do Medicamento, Infarmed, 2022, in: https://extranet.infarmed.pt/INFOMED-fo/detalhes-medicamento.xhtml

Viagra, Resumo das Características do Medicamento, Infarmed, 2008, in: https://www.ema.europa.eu/en/documents/product-information/viagra-epar-product-information_pt.pdf

Cialis, Resumo das Características do Medicamento, Infarmed, 2008, in: https://www.ema.europa.eu/en/documents/product-information/cialis-epar-product-information_pt.pdf

Levitra, Resumo das Características do Medicamento, Infarmed, 2008, in: https://www.ema.europa.eu/en/documents/product-information/levitra-epar-product-information_pt.pdf

Spedra, Resumo das Características do Medicamento, Infarmed, 2018, in: https://www.ema.europa.eu/en/documents/product-information/spedra-epar-product-information_pt.pdf

Vitaros, Resumo das Características do Medicamento, Infarmed, 2021, in: https://extranet.infarmed.pt/INFOMED-fo/pesquisa-avancada.xhtml

Caverject, Resumo das Características do Medicamento, Infarmed, 2020, in: https://extranet.infarmed.pt/INFOMED-fo/pesquisa-avancada.xhtml

Published

2025-02-06

Issue

Section

Original Article